Geneos Wealth Management’s Akoustis Technologies Inc AKTS Stock Holding History
Bought
Maintained
Sold
Other funds holding AKTS
HIM
SAM
TFCM
PCM
SM
SIG
AIC
Geneos Wealth Management's AKTS Position: Q1 2024 in Review
Geneos Wealth Management sold out of Akoustis Technologies Inc (AKTS) in Q1 2024, closing a stake of 700 shares — an estimated $581 sold.
Geneos Wealth Management first reported a position in AKTS in Q1 2023 and held it in 4 quarters. The position peaked at $2.23K in Q2 2023. 118 funds tracked by Wall St. Rank hold AKTS as of Q1 2024.
- Geneos Wealth Management reported no remaining Akoustis Technologies Inc position as of Q1 2024 after selling out during the quarter.
- Geneos Wealth Management sold 700 Akoustis Technologies Inc shares in Q1 2024, an estimated $581.
- Geneos Wealth Management first reported a position in Akoustis Technologies Inc in Q1 2023 and held it in 4 quarters.
- Geneos Wealth Management's Akoustis Technologies Inc position peaked at $2.23K in Q2 2023.
- 118 funds tracked by Wall St. Rank held Akoustis Technologies Inc as of Q1 2024.
Based on Geneos Wealth Management's 13F filing for Q1 2024, filed 3 May 2024.